Stock listing
Zenas Biopharma, Inc.
Selected listing: ZBIO · NASDAQ · USD · US
Zenas Biopharma, Inc. (NASDAQ:ZBIO), Health Technology. Latest release Oct 6, 2026: Zenas BioPharma to Host Virtual R&D Event.
- Ticker
- NASDAQ:ZBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Zenas Biopharma, Inc.
Zenas Biopharma, Inc. is a public company traded under the ticker ZBIO in the American market. Zenas Biopharma focuses on developing innovative biopharmaceuticals to address unmet medical needs.
Latest news from Zenas Biopharma, Inc.
Zenas BioPharma to Host Virtual R&D Event
October 6, 2026
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
September 22, 2026
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
September 8, 2026
Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
June 2, 2026
Research Zenas Biopharma, Inc.
Zenas Biopharma, Inc. company profile
View the public company page for Zenas Biopharma, Inc. on 6ix.
Zenas Biopharma, Inc. news
Read company news and market updates connected to Zenas Biopharma, Inc..
Zenas Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Zenas Biopharma, Inc..